1. Home
  2. CLBT vs IRON Comparison

CLBT vs IRON Comparison

Compare CLBT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$14.54

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$75.44

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
IRON
Founded
1999
2017
Country
Israel
United States
Employees
1285
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CLBT
IRON
Price
$14.54
$75.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$22.50
$103.18
AVG Volume (30 Days)
1.5M
441.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.45
N/A
Revenue Next Year
$17.47
$283.52
P/E Ratio
$45.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.03
$40.00
52 Week High
$19.98
$99.50

Technical Indicators

Market Signals
Indicator
CLBT
IRON
Relative Strength Index (RSI) 47.78 51.85
Support Level $12.53 $70.29
Resistance Level $15.15 $82.65
Average True Range (ATR) 0.64 3.33
MACD -0.15 -0.16
Stochastic Oscillator 24.49 49.48

Price Performance

Historical Comparison
CLBT
IRON

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: